Would you utilize splenic radiation for patients with non-myeloid malignancy and splenomegaly in the setting of platelet sequestration, which is limiting cytotoxic systemic therapy options?

More specifically, in a patient with prior bilateral liver radioembolization leading to radiation-induced liver disease and associated portal hypertension, would radiation to the spleen improve low platelets in this setting?